Pinnacle Financial Group, Inc.’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Buy
+117,000
New +$1.3M 0.12% 148

Other funds holding CADL

Pinnacle Financial Group, Inc.'s CADL Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Candel Therapeutics (CADL) in Q3 2026: 117,000 shares worth $1.22M. The stake represents 0.12% of the portfolio and ranks #148 among its holdings.

139 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 117,000 shares of Candel Therapeutics worth $1.22M as of Q3 2026.
  • Candel Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Candel Therapeutics made up 0.12% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #148 holding.
  • 139 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.